Cargando…
Progress in Structure Based Drug Design for G Protein-Coupled Receptors
Autores principales: | Congreve, Miles, Langmead, Christopher J., Mason, Jonathan S., Marshall, Fiona H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2011
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308205/ https://www.ncbi.nlm.nih.gov/pubmed/21615150 http://dx.doi.org/10.1021/jm200371q |
Ejemplares similares
-
Discovery of 1,2,4-Triazine
Derivatives as Adenosine
A(2A) Antagonists using Structure Based Drug Design
por: Congreve, Miles, et al.
Publicado: (2012) -
Identification of Novel
Adenosine A(2A) Receptor
Antagonists by Virtual Screening
por: Langmead, Christopher J., et al.
Publicado: (2012) -
Biophysical
Fragment Screening of the β(1)-Adrenergic Receptor:
Identification of High Affinity Arylpiperazine Leads Using Structure-Based
Drug Design
por: Christopher, John A., et al.
Publicado: (2013) -
A minimal ligand binding pocket within a network of correlated mutations identified by multiple sequence and structural analysis of G protein coupled receptors
por: Moitra, Subhodeep, et al.
Publicado: (2012) -
Structure‐Guided Design of G‐Protein‐Coupled Receptor Polypharmacology
por: Kampen, Stefanie, et al.
Publicado: (2021)